Molecular characterization of two Chinese pedigrees with maternally inherited hypertension

Abstract

Background Mutations in mitochondrial tRNA (mt‐tRNA) genes are associated with hypertension, although their pathogenic mechanisms remain poorly understood. Methods In the present study, two Han Chinese families with maternally transmitted hypertension were interviewed. The mtDNA mutations of matrilineal relatives were screened by polymerase chain reaction‐Sanger sequencing. Mitochondrial ATP, membrane potential and reactive oxygen species (ROS) were also analyzed in polymononuclear leukocytes carrying these mt‐tRNA mutations. Additionally, the levels of oxidative stress‐related biomarkers [malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GSH‐Px) and 8‐hydroxy‐2‐deoxyguanosine (8‐OHdG)] were analyzed. Results Nine of 13 adult matrilineal relatives of these pedigrees exhibited a wide range of severity of hypertension. The age at onset of hypertension was 30–62 years (average 46 years). Mutational screening of mitochondrial genomes revealed tRNAArg T10410C and T10454C mutations. Indeed, the m.T10454C and m.T10410C mutations occurred at conserved bases of TΨC‐loop and acceptor arm of tRNAArg (positions 55 and 6), which are critical for tRNAArg post‐transcriptional modification. Thus, the defects in tRNA modification may cause failure in tRNA metabolism, impairing mitochondrial translation. Biochemical analysis revealed that m.T10454C or m.T10410C mutation significantly reduced mitochondrial ATP and membrane potential and also increased ROS production in mutant cell lines (all p < 0.05). In addition, the levels of MDA and 8‐OHdG in hypertensive patients markedly increased, whereas those of SOD and GSH‐Px decreased (all p < 0.05). Conclusions These findings demonstrate that m.T10410C and m.T10454C mutations affect the structure and function of tRNAArg and consequently alter mitochondrial function and lead to oxidative stress, which are involved in the pathogenesis of maternally inherited hypertension.

Maternally transmitted nonsyndromic hearing impairment may be associated with mitochondrial tRNAAla 5601C>T and tRNALeu(CUN) 12311T>C mutations

“…The Cell Titer‐Glo ® Luminescent Cell Viability Assay kit (Promega, Madison, USA) was used to determine the ATP production in mutant cell lines carrying tRNA mutations and the controls, using the protocol provided by the manufacturer. 33 …”

The Role of Mitochondrial DNA Mutations in Cardiovascular Diseases

“…A recent study showed that the Mt3253 (T > C) mutation (tRNA Leu(UUR) ) resulted in the decreased activity of mitochondrial complexes I and V, leading to 66% lower ATP production, reduced membrane potential and the increased production of ROS [57]. Similarly, the Mt10454 (T > C) and Mt10410 (T > C) mutations significantly reduced mitochondrial ATP and membrane potential, increased ROS production and raised the levels of MDA (malondialdehyde) and 8-OhdG (8-Oxo-2'-deoxyguanosine), while levels of SOD (superoxide dismutase) and GSH-Px (glutathione peroxidase) were decreased [56]. Cell lines carrying the Mt4467 (C > A) mutation (tRNA Met ) had decreased oxygen consumption, 26.2% lower mitochondrial membrane potential, 26.4% lower ATP level, and 114.5% higher ROS production [61].…”

Mitochondrial Diabetes is Associated with tRNALeu(UUR) A3243G and ND6 T14502C Mutations

“…We compared human mtDNA nucleotide variation with 16 species to determine the conservation index (CI). 34 A CI ≥ 75% was regarded as having functional potential. 35 …”